CBT

Cabot Corporation Basic Materials - Specialty Chemicals Investor Relations →

YES
11.0% BELOW
↓ Approaching Was -8.8% last week
-15% -10% -5% 0% 5% 10% 15%+
Buy Threshold $76.21
14-Week RSI 50
Rel. Volume (14w) This week's trading vs. the 14-week average 1.4x
Buyers vs. Sellers (14w) Are up-weeks or down-weeks getting more volume? 0.78

Cabot Corporation (CBT) closed at $67.82 as of 2026-03-20, trading 11.0% below its 200-week moving average of $76.21. This places CBT in the extreme value zone. The stock is currently moving closer to the line, down from -8.8% last week. The 14-week RSI sits at 50, indicating neutral momentum.

Trading volume is running at 1.4x of its 14-week average, which is in the normal range. The balance between buying and selling volume (0.78 ratio) is neutral — neither side is clearly dominating.

Over the past 2319 weeks of data, CBT has crossed below its 200-week moving average 36 times. On average, these episodes lasted 17 weeks. Historically, investors who bought CBT at the start of these episodes saw an average one-year return of +26.4%.

With a market cap of $3.5 billion, CBT is a mid-cap stock. The company generates a free cash flow yield of 8.2%, which is notably high. Return on equity stands at 21.8%, indicating strong profitability. The stock trades at 2.2x book value.

The company has been aggressively buying back shares, reducing its share count by 6.1% over the past three years.

Over the past 33.2 years, a hypothetical investment of $100 in CBT would have grown to $2386, compared to $2683 for the S&P 500. CBT has returned 10.0% annualized vs 10.4% for the index, underperforming the broader market over this period.

Free cash flow has been volatile over the past several years, making the quality of earnings harder to assess.

Business Health

Annual financials — how the underlying business has performed over the past several years.

Cash Flow Free cash flow & net income ($M)

Revenue Annual revenue ($M) — business growth proxy

Total Debt Balance sheet debt ($M)

ROIC Return on invested capital (%)

FCF Yield Free cash flow / market cap (%) — Yartseva signal

Gross Margin Pricing power & competitive moat (%)

Shares Outstanding Buybacks vs dilution (millions)

Growth of $100: CBT vs S&P 500

Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.

What Happens After CBT Crosses Below the Line?

Across 25 historical episodes, buying CBT when it crossed below its 200-week moving average produced an average return of +23.4% after 12 months (median +23.0%), compared to +12.0% for the S&P 500 over the same periods. 68% of those episodes were profitable after one year. After 24 months, the average return was +50.2% vs +20.6% for the index.

Each line shows $100 invested at the moment CBT crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.

Advertisement

Historical Touches

CBT has crossed below its 200-week MA 36 times with an average 1-year return of +26.4% after recovery.

Crossed BelowRecoveredWeeksMax Depth1-Year ReturnReturn Since Touch
Oct 1981Feb 19836938.4%-4.8%+4467.0%
Aug 1983Sep 198352.2%-4.9%+4555.7%
Dec 1983Jan 198443.6%+0.5%+4578.4%
Jan 1984Mar 198455.5%+18.9%+4555.7%
Mar 1984Aug 19842311.9%+8.3%+4555.7%
Aug 1985Oct 1985916.3%+25.9%+4719.4%
Jan 1986Feb 198655.1%+39.2%+4749.5%
Mar 1986Mar 198611.6%+49.1%+4678.9%
Nov 1987Dec 198713.5%+35.8%+4049.3%
Oct 1989Nov 198922.6%-20.2%+3206.2%
Jan 1990Mar 19916031.7%-12.7%+3109.0%
Apr 1991Sep 19912010.9%+48.4%+3029.5%
Nov 1991Dec 1991510.1%+55.8%+3223.1%
Aug 1998Oct 1998912.4%-3.7%+785.8%
Jan 1999Apr 19991425.1%-6.5%+738.2%
May 1999Mar 20004329.2%+5.2%+728.5%
Oct 2000Oct 2000125.4%+259.7%+986.2%
Sep 2002Oct 200259.9%+39.0%+427.8%
Feb 2003Mar 200369.3%+40.5%+394.3%
Apr 2003Apr 200311.4%+43.2%+389.3%
May 2005Jun 200568.4%+22.3%+274.7%
Sep 2007Oct 200710.5%-9.2%+199.3%
Oct 2007Feb 201012074.3%-28.7%+204.8%
May 2010Jun 201035.7%+53.0%+251.4%
Jun 2010Jul 2010515.8%+48.1%+267.2%
Sep 2011Oct 201137.6%+56.7%+280.6%
Dec 2014Dec 201413.3%+6.4%+124.5%
Jun 2015Nov 20152322.6%+14.6%+113.3%
Dec 2015Feb 20161010.2%+33.4%+111.0%
Oct 2018Oct 201811.9%-2.3%+69.8%
Nov 2018Jan 202111157.1%+3.0%+73.0%
Jan 2021Feb 202114.4%+29.9%+73.1%
May 2025May 202530.5%N/A-6.0%
Jun 2025Jun 202511.7%N/A-5.6%
Jul 2025Aug 202534.3%N/A-7.8%
Sep 2025Ongoing25+19.6%Ongoing-8.6%
Average17+26.4%

Frequently Asked Questions

Is CBT below its 200-week moving average?

Yes. As of 2026-03-20, Cabot Corporation (CBT) is trading 11.0% below its 200-week moving average of $76.21. The current price is $67.82.

What is CBT's 200-week moving average price?

Cabot Corporation's 200-week moving average is $76.21 as of 2026-03-20. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.

What happens when CBT drops below its 200-week moving average?

CBT has crossed below its 200-week moving average 36 times in our data. On average, buying at that moment produced a one-year return of +26.4%. These dips have historically been decent entry points. These episodes lasted 17 weeks on average.

Is CBT a good value right now?

Here's what our data says about CBT as of 2026-03-20: The stock is below its 200-week moving average, which is the starting point for our analysis. The 14-week RSI is 50. Free cash flow yield is 8.2%. Return on equity is 21.8%. Price-to-book is 2.2x. This is not a buy or sell recommendation — always do your own research.

How does CBT compare to the S&P 500?

Over the past 33.2 years, $100 invested in CBT would have grown to $2386, compared to $2683 for the S&P 500. That's 10.0% annualized vs 10.4% for the index. CBT has underperformed the broader market over this period.

Does CBT pay a dividend?

Yes. Cabot Corporation currently pays a dividend yield of 265.00%.

Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.

Data as of week of 2026-03-20